Germline Risks and Clinical Impacts of DDX41 Mutations in Myeloid Malignancies

Autor: Makishima, Hideki, Saiki, Ryunosuke ^*, Nannya, Yasuhito, Korotev, Sophia C. ^*, Gurnari, Carmelo, Takeda, June ^*, Momozawa, Yukihide ^*, Best, Steve ^*, Krishnamurthy, Pramila ^*, Yoshizato, Tetsuichi, Atsuta, Yoshiko ^*, Shiozawa, Yusuke ^*, Iijima-Yamashita, Yuka ^*, Yoshida, Kenichi, Shiraishi, Yuichi ^*, Nagata, Yasunobu ^*, Kakiuchi, Nobuyuki ^*, Onizuka, Makoto, Chiba, Kenichi ^*, Tanaka, Hiroko ^*, Kon, Ayana ^*, Ochi, Yotaro ^*, Nakagawa, Masahiro Marshall, Okuda, Rurika ^*, Mori, Takuto ^*, Yoda, Akinori ^*, Itonaga, Hidehiro, Miyazaki, Yasushi, Sanada, Masashi, Ishikawa, Takayuki, Chiba, Shigeru, Tsurumi, Hisashi, Kasahara, Senji, Müller-Tidow, Carsten ^*, Takaori-Kondo, Akifumi, Ohyashiki, Kazuma, Kiguchi, Toru ^*, Matsuda, Fumihiko ^*, Jansen, Joop H., Polprasert, Chantana ^*, Blombery, Piers, Kamatani, Yoichiro ^*, Miyano, Satoru ^*, Malcovati, Luca, Haferlach, Torsten, Kubo, Michiaki ^*, Cazzola, Mario, Kulasekararaj, Austin, Godley, Lucy A., Maciejewski, Jaroslaw P., Ogawa, Seishi

Publikováno v: In Blood 15 November 2022 140 Supplement 1:208-210